The emerging clinical relevance of cell-free DNA in lupus: from mechanistic insights to therapeutic opportunities

• by Emily Jones, Kiki Cano-Gamez

• June 23, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Case Report: A “visceral vasculitis storm” in Systemic Lupus Erythematosus: simultaneous enteritis, ureteritis, and splenic infarction in a pediatric patient

• by Xia Wu, Yan Liu, Huan He

• July 9, 2026

A Pragmatic Trial of a Shared Decision-Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ-SAFE Study

• by Caroline Packee, Jay J. Patel, Jessica Kent, Betty Chewning, Sancia Ferguson, Patricia Tellez-Giron, David Gazeley, Christie M. Bartels, Shivani Garg

• June 4, 2026